医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ZRG Partners Releases Q2 2016 Global Life Sciences Hiring Index

2016年08月29日 PM11:53
このエントリーをはてなブックマークに追加


 

ROCHELLE PARK, N.J.

ZRG Partners has announced the findings for the second quarter Global Life Sciences Hiring Index. 2016 has shown an increase in hiring demand consistently, posting 50% higher than the same period last year.

Medical Device continued to show historically high index numbers, as did BioPharma. Outsourcing / Services decreased for the second quarter in a row, however still posted higher than Q2 2015. Q2 2016 marks the first quarter that ZRG has collected data from the South America region.

ZRG European President and Global Practice Head of Life Sciences, Adam El Din commented, “The financing of startup med techs remains tough, as the number of potential acquirers has shrunk with industry consolidation. Investors still don’t see clear paths to exit. But that may be improving as the IPO market loosens.”

David Fortier, Managing Director – Global Life Sciences added, “These results are an encouraging sign for the industry. As the economy continues to strengthen slowly in the U.S., workers may be more willing to change employers and the growing inability or unwillingness of many companies to develop internal talent results in greater external hiring activity.”

About ZRG Partners

ZRG Partners, LLC is a global authority on talent management in the Life Sciences, Pharmaceutical and Medical Device markets. ZRG provides its clients with specialized global market expertise in executive recruitment, consulting and advisory work with a focus on data and analytics to drive great business decisions.

The Global Life Sciences Hiring Index analysis utilizes a proprietary algorithm that looks at hiring within selected benchmark companies in three distinct segments. The companies in the index generate over $630 billion in revenues and employ over 1.5 million people globally. ZRG Partners conducts extensive direct market research in developing the data that drives the Index.

For more information about ZRG visit zrgpartners.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160829005667/en/

CONTACT

For press requests or for permission to use this data in other media
form:
ZRG Partners, LLC
Switzerland
Adam El Din,
+41-22-319-3304
European President and Global Practice Head of Life
Sciences
or
USA
David Fortier, +1-202-525-1341
Managing
Director

同じカテゴリーの記事 

  • Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
  • ReNAgade Therapeutics宣布在ASGCT第27届年会上发表演讲
  • ReNAgade TherapeuticsがASGCT第27回年次総会でのプレゼンテーションの内容を発表
  • BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
  • The 2024 Japan Prize Award Ceremony Is Held with Their Majesties the Emperor and Empress of Japan in Attendance